A b s t r a c t
Different error detection methods yield different error proportions and have variable benefits for surgical pathology divisions with limited resources.
We performed a nonconcurrent cohort study at a large institution that practices subspecialty surgical pathology sign-out to compare the effectiveness and usefulness of error detection using a targeted 5% random review process and a focused review process. Pathologists reviewed 7,444 cases using a targeted 5% random review process and 380 cases using a focused review process. The numbers of errors detected by the targeted 5% random and focused review processes were 195 (2.6% of reviewed cases) and 50 (13. 
2%), respectively (P < .001). The numbers of major errors for the targeted 5% random and focused review processes was 27 (0.36%) and 12 (3.2%), respectively (P < .001). Focused review detects a higher proportion of errors and may be more effectively used for design of error reduction initiatives.
Anatomic pathology secondary case review is a method of error detection, and different methods of secondary review yield different error proportions. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] A College of American Pathologists Q-Probes study 2 reported that the mean proportion of error in 74 institutions performing a variety of secondary review methods was 6.7%; these secondary review methods included external and internal departmental conferences, interdepartmental and extradepartmental consultation, correlation, clinician requested, and other internal quality assurance review monitors.
Depending on the method, secondary review may be time-consuming and costly in terms of departmental resources. Departments that have limited resources are not able to perform all types of secondary review. One benefit of error detection lies in using these data for improvement. [11] [12] [13] Formal cost-effectiveness studies of secondary review processes have not been performed, and the link between secondary review error detection and patient outcome rarely has been established beyond anecdotal assessments. The inability to change practices following error detection results in anxiety and lessens the inclination to search for error. 14, 15 We report on 1 study site that participated in an Agency for Healthcare Research and Quality project 11 to evaluate baseline error proportions and the effectiveness of using these error data for process redesign and improvement. This site practices subspecialty organ-based case sign-out (eg, gastrointestinal, bone and soft tissue, and genitourinary tract pathology sign-out). 16 Before 2006, a main secondary case review method was a random process in which a target of 5% of all histopathologic cases were reviewed. Many pathologists reported that the amount of work inherent in a 5% random review process was high and that the benefit of this review process was extremely low. Following a pilot study in late 2005, a focused review process was implemented in 2006. In the focused review process, the subspecialty directors reviewed cases representing a diagnostically challenging area (eg, chondroid lesions) or an area in which there was a perceived lack of standardization (eg, diagnosis of Helicobacter pylori in gastric specimens).
The goal of this study was to compare the effectiveness of error detection using the targeted 5% random and focused review processes. We also measured the effect of these errors on patient outcomes 11 and qualitatively assessed the strengths and benefits of both review methods.
Materials and Methods

Study Site
This study was conducted in a large multihospital system that practiced subspecialty organ-based sign-out 16 involving bone and soft tissue, genitourinary tract, head and neck, thoracic, neurologic, transplant, gastrointestinal, and breast pathology. This site was deidentified because of internal concerns about reporting error data. We obtained internal review board approval for this project.
Quality Assurance Division Secondary Review Time Frame
Quality assurance activities were coordinated by divisional staff, consisting of 1 to 2 people, and were overseen by a committee. The staff assisted in the performance of a targeted 5% random secondary review process from January 1, 2001, to December 31, 2005, and a focused secondary review process from January 1, 2006, to December 31, 2006. Staff members coordinated the pulling of slides and reports; data collection, entry, and analysis; and clinical outcome review. The staff designed a data collection form that identified the secondary reviewer, specific disagreement (or error), and an assessment of the clinical severity of the error.
The quality assurance committee membership and oversight review processes changed during the time frame of the study, as new faculty members arrived in the department. The committee was composed of the director of quality assurance and an additional 4 to 8 pathologists. This committee served as an adjudicative body to perform informal root cause analysis and to qualitatively assess the severity of errors.
The pathologists assessed the error clinical severity, which was classified as major or minor. A disagreement that potentially affected clinical care was classified as major (eg, a change in diagnosis from benign to malignant), and a disagreement that presumably did not affect patient care was classified as minor. Examples of minor discrepancies included typographical errors and slight changes in diagnoses that often involved a single "step" difference (eg, a bladder biopsy diagnosis changed from carcinoma in situ to highgrade dysplasia). At this stage of the process, adjudication of error severity was not based on clinical record review.
As an attempt to reduce individual pathologist subjectivity in error severity assessment, all interpretation errors detected by retrospective review processes were reevaluated and adjudicated by committee members. From 2001 to 2004, the quality assurance committee members met quarterly to discuss the cases of major disagreement; if the majority of committee members did not concur with the original pathologist's assessment of major error, the error severity was classified as minor. In 2005, cases were forwarded to the subspecialty director of service who readjudicated whether the error was major or minor. This change was made because some pathologists believed that subspecialty pathologists had greater expertise, compared with the general committee, in assessing the potential level of harm for specific case types. The assessment of a major or minor error was conveyed to the sign-out pathologist, and if this pathologist disagreed with this assessment, the entire committee would rereview the case. This appeal process was created to allay the fear of targeting.
Targeted 5% Random Review
In the targeted 5% random secondary case review process, we used a laboratory information system (CoPath Plus Anatomic Pathology, Cerner, Kansas City, MO) to identify 5% of surgical pathology cases accessioned the previous month. Cases without a histologic examination (ie, grossonly cases) were excluded and replaced by cases chosen arbitrarily by the quality assurance staff to raise the number of cases to approximately 5% zTable 1z. Thus, the slide selection process was not entirely random, but we use the term random to avoid confusion. The glass slides and final reports from these cases were retrieved from departmental files, and missing cases were replaced by cases arbitrarily chosen by the quality assurance staff. All practicing pathologists were sent cases for review, although not all pathologists completed the review process because of time constraints and other factors. Approximately 30 pathologists participated. Thus, in some years, fewer than 5% of cases were reviewed. In several of the study years, the quality assurance staff selected "extra" cases to ensure that at least 5% of all surgical pathology cases were reviewed.
Focused Review
The quality assurance committee discussed the change from the targeted 5% random review to focused review in 2005, and a pilot focused review project was performed in the fall of 2005. The pilot project involved the evaluation of thyroid gland excision specimens (head and neck subspecialty) originally diagnosed as a follicular neoplasm (ie, adenoma or carcinoma); the intent of this review was to examine the use of specific diagnostic terminology and histologic criteria. Following discussion of the pilot results, the committee voted to implement focused review in all subspecialty services in 2006 for several reasons. Pathologists reported that the targeted 5% random review was extremely time-consuming, detected few disagreements of consequence, and was not useful in a system that performed subspecialty sign-out (as pathologists lacked sufficient expertise to review subspecialty cases that they did not normally sign-out). The pathologist who performed the pilot study thought that focused review allowed for greater evaluation of challenging case types and provided information for diagnostic standardization.
In 2006, the committee requested that a quality assurance representative from each subspecialty choose a specific area for focused review. The representatives were asked to focus on areas in which there was a perceived higher level of diagnostic uncertainty or lack of standardization in terminology. 17 The committee proposed a schedule that assigned each subspecialty a specific quarter in which to perform its review. Three subspecialties completed the focused review process: (1) The gastrointestinal subspecialty division evaluated gastric biopsy specimens to determine the accuracy of a negative diagnosis of H pylori when a special stain (Giemsa or immunohistochemical) was not obtained and colectomy specimens to determine the variability in cancer reporting in gross diagnosis, final diagnosis, synoptic reporting, and ancillary molecular pathology testing. (2) The bone and soft tissue subspecialty division evaluated chondroid lesions and welldifferentiated lipoma-like liposarcoma/atypical lipomatous tumors (WDLS/ALT) to determine the effect of inadequate sampling and the lack of clinical and radiologic information on error proportion. (3) The genitourinary subspecialty division evaluated bladder biopsy specimens to determine the effect of focused secondary review on error detection.
For each focused review, we performed a sample size calculation assuming a case error proportion ranging from 2% to 5%, based on input from the subspecialty representatives. For the gastric, colectomy, chondroid, WDLS/ALT, and bladder specimens, subspecialty pathologists reviewed 100, 87, 61, 73, and 59 cases, respectively. In the focused areas, cases generally were selected consecutively and a specific data collection form was prepared. The members of the subspecialty areas were allowed the flexibility to perform the secondary review in a manner of their choosing; in some subspecialty areas, all pathologists participated, and in other areas, the subspecialty director or only senior subspecialty pathologists reviewed cases. Seven pathologists participated in the focused review process.
Impact of Error on Patient Care
Following completion of the focused review projects, the staff of the quality assurance division performed clinical record review for all cases with a major disagreement. The follow-up time for all cases ranged from 5.5 years to 8 months. The staff searched the clinical record for patient management and outcomes items, including additional tests ordered, unnecessary or additional treatment protocols initiated, morbidity and/or mortality related to additional tests or treatments, and delays in diagnosis. 11 These data were deidentified, and a pathologist reassessed the clinical severity of the error. We classified errors into the following categories: We subclassified harm as follows 11 : (1) (4) severe (grade IV): loss of life, limb, or other body part or longlasting morbidity (>6 months).
Statistical Analysis
We compared the proportion of all errors and major errors detected by the targeted 5% random and focused review processes by using a χ 2 test. The error proportion was calculated as the number of errors divided by the total number of cases reviewed. Statistical significance was assumed with a P value of .05 or less.
Results
From 2001 to 2006, pathologists reviewed 7,444 cases (3.5% of all surgical pathology cases) using a targeted 5% random review process, and in 2006, pathologists reviewed 380 cases (0.70% of all cases) using a focused review process. The numbers of errors detected by the targeted 5% random and focused review processes were 195 (2.6% of reviewed cases) and 50 (13.2%), respectively (P < .001) ( Table 1 ). The numbers of major errors for the targeted 5% random and focused review processes were 27 (0.4%) and 12 (3.2%), respectively (P < .001). For the gastric, colectomy, chondroid, WDLS/ALT, and bladder specimens, the numbers of major errors detected were 4 (4.0%), 5 (6%), 0 (0%), 3 (4%), and 0 (0%), respectively. The numbers of minor errors detected for these specimen types were 0 (0%), 25 (29%), 5 (8%), 5 (7%), and 3 (5%), respectively.
The individual major disagreements are shown in zTable 2z and zTable 3z, which also provide the medical record review for error severity assessment. For the major disagreements detected by the targeted 5% random secondary review process, harm was observed in 11 cases (41%) and was further classified as minimal, mild, and moderate in 5, 4, and 2 cases, respectively. For the major disagreements detected by the focused review process, harm was observed in 7 cases (58%) and always was classified as minimal. Harm was seen in 18 (46%) of all major errors, and moderate harm was associated with 2 major errors (5%; 0.026% of all reviewed cases).
Discussion
Our findings indicate that in a surgical pathology subspecialty sign-out practice, focused review detected a far higher proportion of error than targeted 5% random review. Targeted 5% random review and focused review have different qualities 18 random review process are that error detection is not limited to any specific specimen type and that pathologists may be exposed to a variety of sign-out styles in a large-volume practice. For a subspecialty practice, weaknesses are that the lack of subspecialty expertise limits error detection and that bias limits error detection in reviewing common case types, in which unexpected findings are unusual.
On a percentage basis, the focused review process detected approximately 4 times the number of errors compared with the targeted 5% random review process, even though the targeted 5% random review process involved the examination of almost 20 times the number of specimens. A possible explanation is that in the focused review process, subspecialty-oriented pathologists spent considerably more
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Comment Severity time reexamining specimens for which they had expertise. Depending on the subspecialty, our focused review process incorporated root cause analysis and quality improvement by focusing on specific problem areas. 4, [20] [21] [22] The targeted 5% random review process detected isolated incidents of error that generally were difficult to link to overall error patterns for specific subspecialty specimen types. Similar to College of American Pathologists Q-Probes multi-institutional secondary review data, 2 our focused review data indicated that specific surgical pathology areas were more prone to error than other areas. 10, 17 For example, in the bone and soft tissue subspecialty service, more major errors were detected in cases diagnosed as WDLS/ALT than in chondroid lesions, perhaps reflecting differences in expertise. All subspecialty reviews showed a lack of diagnostic standardization and low levels of disagreement that may appear surprising as small numbers of pathologists constituted the subspecialty services. We hypothesize that these levels of disagreement are inherent in practices that lack methods of diagnostic standardization. 23, 24 Many surgical pathology practices recognize problematic areas of diagnosis and use standardizing error reduction procedures, 2 such as local expert or secondary review consultation for particular case types before sign-out (eg, all "first diagnosis" of malignancy or breast core biopsy cases are secondarily reviewed before sign-out). [25] [26] [27] [28] [29] These presign-out error reduction methods are forms of prospective focused review based on expert or group opinion. A benefit of prospective focused review is that standardization occurs on a relatively frequent basis whenever the secondary review is performed. Double viewing detects the rare "obvious" diagnostic misclassification, but more important, creates a framework for consensus of diagnostic criteria. 4 A benefit of retrospective focused review is that evaluation of a large case set may produce more data and identify unknown areas of discrepancy. [3] [4] [5] [6] [7] [8] [9] [10] In our study, the areas chosen for focused review were not generally known for having a high risk of interpretation error, although the subspecialty directors thought these areas may be areas of possible high disagreement. Other subspecialty areas reported in the literature with higher disagreement proportions include melanocytic lesions of the skin, breast lesions, and prostate needle biopsy tissues. 2, 7, 8 The focused review process examined relatively small numbers of cases to determine if specific subspecialty areas possibly were associated with a higher level of diagnostic disagreement. Thus, we specifically focused on potential problem areas. If more cases in the focused area had been chosen for retrospective review, we expect that a similar proportion of disagreement would have been obtained. Institutions and departments have varying cultures of patient safety and quality improvement. 14 Similarly, the safety and quality cultures of the study site surgical pathology subspecialty services also differed, as evidenced by the lack of participation of some subspecialty services in the focused review process. Multiple reasons for not participating were provided; the challenge of moving from a system in which all pathologists passively reviewed randomly chosen slides to a system in which the subspecialty pathologists constructed their own review process was not always surmountable for implicit and explicit reasons. Some subspecialty pathologists viewed that their areas were not prone to error. Some pathologists did not want to assume the responsibility for choosing an area of review and were unhappy that the random review was discontinued, as their role in that process was simply to evaluate the cases that were sent to them. Some pathologists thought that their reviewing focused cases would entail too much work compared with the random process. Many pathologists did not recognize the underlying level of diagnostic disagreement inherent in their subspecialty.
Harm was associated with 46% of all major errors and with 1.8% of cases reviewed by the focused process. 11 The significance of this finding depends on perspective. On one hand, the majority of errors detected by focused and random review did not lead to patient harm, and, when harm occurred, it generally was adjudicated as low grade. Compared with the interpretation errors detected by secondary review, errors associated with preanalytic and postanalytic surgical pathology testing phases are much more common and associated with more severe harm. On the other hand, low-grade harm consists of outcomes such as unnecessary testing, delays in diagnosis, increased costs, and patient anxiety; these errors arise from process failures that lie within the analytic testing phase under the domain of pathology and, presumably, could be targeted for improvement. 11 The degree to which diagnostic disagreement is irreducible will only be known when the science of standardization and implementation are fully adopted in pathology. Current challenges are in acknowledging that a proportion of diagnostic discrepancies results in patient harm and in designing interventions to reduce the frequency of diagnostic discrepancies. Our data indicate that the introduction of subspecialty sign-out does not necessarily eliminate these disagreements in systems that lack internal diagnostic standardization procedures. Our subspecialty practice data are similar to those reported in academic center secondary consult review practice, 25, 30 which typically reveal the lack of diagnostic standardization among practice groups.
We believe that the focused review method is a better method than the random review method for detecting errors secondary to nonstandardized practices in specific subspecialty surgical pathology practices. In the focused review method, a relatively small number of subspecialty cases may be reviewed to determine the disagreement rate; if this rate is high, a standardization procedure may be implemented to lower the disagreement proportion. If the focused review method shows a low disagreement proportion, then other areas may be examined instead of focusing on this area. The random review process is not centered on subspecialty specimen types. The random review process may be used to detect errors across the entire spectrum of surgical pathology subspecialties but does not immediately yield an error proportion for specific subspecialties (as most random review processes measure overall error proportions and not error proportions for specific specimen types). For example, in the random review process, we did not collect random review denominator data on individual subspecialty types (eg, colon specimens for cancer). The random review process may be used to focus on general practice problems that could be standardized and could be used as a preliminary study that will lead to a focused review on individual subspecialty processes that may be more error prone.
We believe that error detection using processes such as targeted 5% random review detect few errors, are costly in terms of departmental resources, and are difficult to use in quality improvement schemes. Error detection using our focused review processes detected problem areas in which diagnostic standardization was lacking. Although we do not report on the use of these data for improvement, we believe these data serve as a starting point for formal diagnostic consensus building and standardization. Focused review can be a method to standardize diagnostic practice.
